DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Referenz

Kwo P, Gane E, Peng CY. et al.
Efficacy and safety of Grazoprevir/Elbasvir plus/–RBV for 12 weeks in patients with HCV G1 or G4 infection who previously failed peginterferon/RBV: C-EDGE treatment-experienced trial.

Journal of hepatology 2015;
62: S674-S675

Bibliographische Angaben herunterladen

Suchen in: